Sign In
to Vote &
Create Storyboards.
 

Discovery May Point to Parkinson's Disease Therapies

Neuroscience News - 30 May 2021 23:39
Discovery May Point to Parkinson's Disease Therapies In Parkinson's disease, alpha-synuclein binds to LC3B. Normally, LC3B causes misfolded proteins to become degraded, but in the case of Parkinson's, LC3B becomes trapped in protein aggregates and becomes inactive.
0
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard